BioCentury
ARTICLE | Clinical News

M&E Biotech starts cancer Phase I/II

April 12, 2000 7:00 AM UTC

M&E Biotech (Horsholm, Denmark) and partner Ferring started a U.K. 30-patient Phase I/II trial of TNF alpha AutoVac to treat cancer-related cachexia. The compound is designed to trigger patients to pr...